Latest / Science News Today | 2 Min News | The Daily News Now!
Telmisartan Could Boost Cancer Drug Efficacy | Science News
A breakthrough combo could soon change cancer treatment: scientists are finding that telmisartan, a common blood pressure drug, may dramatically boost the effectiveness of olaparib, a PARP inhibitor used for DNA-repair-deficient cancers. While olaparib only works for a subset of patients, telmisartan appears to make tumors vulnerable to it—even without the usual genetic mutations. The duo seems to amplify DNA damage and activate the immune system, helping the body recognize and attack cancer. Telmisartan’s unique properties may also help cancers evade immune defenses. Since it’s already…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.